Literature DB >> 34606255

PRM-LIVE with Trapped Ion Mobility Spectrometry and Its Application in Selectivity Profiling of Kinase Inhibitors.

He Zhu1,2, Scott B Ficarro1,2, William M Alexander1,2, Laura E Fleming1,2, Guillaume Adelmant1,2, Tinghu Zhang3, Matthew Willetts4, Jens Decker5, Sven Brehmer5, Michael Krause5, Michael P East6, Nathanael S Gray3, Gary L Johnson6, Gary Kruppa7, Jarrod A Marto1,2,8.   

Abstract

Parallel reaction monitoring (PRM) has emerged as a popular approach for targeted protein quantification. With high ion utilization efficiency and first-in-class acquisition speed, the timsTOF Pro provides a powerful platform for PRM analysis. However, sporadic chromatographic drift in peptide retention time represents a fundamental limitation for the reproducible multiplexing of targets across PRM acquisitions. Here, we present PRM-LIVE, an extensible, Python-based acquisition engine for the timsTOF Pro, which dynamically adjusts detection windows for reproducible target scheduling. In this initial implementation, we used iRT peptides as retention time standards and demonstrated reproducible detection and quantification of 1857 tryptic peptides from the cell lysate in a 60 min PRM-LIVE acquisition. As an application in functional proteomics, we use PRM-LIVE in an activity-based protein profiling platform to assess binding selectivity of small-molecule inhibitors against 220 endogenous human kinases.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34606255      PMCID: PMC9297317          DOI: 10.1021/acs.analchem.1c02349

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   8.008


  45 in total

1.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

2.  Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM).

Authors:  Sebastien Gallien; Sang Yoon Kim; Bruno Domon
Journal:  Mol Cell Proteomics       Date:  2015-03-09       Impact factor: 5.911

3.  Multiplexed, Scheduled, High-Resolution Parallel Reaction Monitoring on a Full Scan QqTOF Instrument with Integrated Data-Dependent and Targeted Mass Spectrometric Workflows.

Authors:  Birgit Schilling; Brendan MacLean; Jason M Held; Alexandria K Sahu; Matthew J Rardin; Dylan J Sorensen; Theodore Peters; Alan J Wolfe; Christie L Hunter; Michael J MacCoss; Bradford W Gibson
Journal:  Anal Chem       Date:  2015-09-30       Impact factor: 6.986

4.  Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors.

Authors:  Tinghu Zhang; Nicholas Kwiatkowski; Calla M Olson; Sarah E Dixon-Clarke; Brian J Abraham; Ann K Greifenberg; Scott B Ficarro; Jonathan M Elkins; Yanke Liang; Nancy M Hannett; Theresa Manz; Mingfeng Hao; Bartlomiej Bartkowiak; Arno L Greenleaf; Jarrod A Marto; Matthias Geyer; Alex N Bullock; Richard A Young; Nathanael S Gray
Journal:  Nat Chem Biol       Date:  2016-08-29       Impact factor: 15.040

5.  PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase.

Authors:  Frauke Leenders; Kristin Möpert; Anett Schmiedeknecht; Ansgar Santel; Frank Czauderna; Manuela Aleku; Silke Penschuck; Sibylle Dames; Maria Sternberger; Thomas Röhl; Axel Wellmann; Wolfgang Arnold; Klaus Giese; Jörg Kaufmann; Anke Klippel
Journal:  EMBO J       Date:  2004-07-29       Impact factor: 11.598

6.  Quantifying proteins by mass spectrometry: the selectivity of SRM is only part of the problem.

Authors:  Mark W Duncan; Alfred L Yergey; Scott D Patterson
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

Review 7.  Breaking the chains: deubiquitylating enzyme specificity begets function.

Authors:  Michael J Clague; Sylvie Urbé; David Komander
Journal:  Nat Rev Mol Cell Biol       Date:  2019-06       Impact factor: 94.444

8.  Targeting transcription regulation in cancer with a covalent CDK7 inhibitor.

Authors:  Nicholas Kwiatkowski; Tinghu Zhang; Peter B Rahl; Brian J Abraham; Jessica Reddy; Scott B Ficarro; Anahita Dastur; Arnaud Amzallag; Sridhar Ramaswamy; Bethany Tesar; Catherine E Jenkins; Nancy M Hannett; Douglas McMillin; Takaomi Sanda; Taebo Sim; Nam Doo Kim; Thomas Look; Constantine S Mitsiades; Andrew P Weng; Jennifer R Brown; Cyril H Benes; Jarrod A Marto; Richard A Young; Nathanael S Gray
Journal:  Nature       Date:  2014-06-22       Impact factor: 49.962

9.  Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MS.

Authors:  Yangyang Bian; Runsheng Zheng; Florian P Bayer; Cassandra Wong; Yun-Chien Chang; Chen Meng; Daniel P Zolg; Maria Reinecke; Jana Zecha; Svenja Wiechmann; Stephanie Heinzlmeir; Johannes Scherr; Bernhard Hemmer; Mike Baynham; Anne-Claude Gingras; Oleksandr Boychenko; Bernhard Kuster
Journal:  Nat Commun       Date:  2020-01-09       Impact factor: 14.919

10.  Progress towards a public chemogenomic set for protein kinases and a call for contributions.

Authors:  David H Drewry; Carrow I Wells; David M Andrews; Richard Angell; Hassan Al-Ali; Alison D Axtman; Stephen J Capuzzi; Jonathan M Elkins; Peter Ettmayer; Mathias Frederiksen; Opher Gileadi; Nathanael Gray; Alice Hooper; Stefan Knapp; Stefan Laufer; Ulrich Luecking; Michael Michaelides; Susanne Müller; Eugene Muratov; R Aldrin Denny; Kumar S Saikatendu; Daniel K Treiber; William J Zuercher; Timothy M Willson
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.